Measures of disease frequency Simon Thornley. Measures of Effect and Disease Frequency Aims – To define and describe the uses of common epidemiological.

Slides:



Advertisements
Similar presentations
From study objectives to analysis plan Helen Maguire.
Advertisements

How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
Principles of Epidemiology Lecture 10 Dona Schneider, PhD, MPH, FACE
Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
KRUSKAL-WALIS ANOVA BY RANK (Nonparametric test)
Study Designs in Epidemiologic
Introduction to Epidemiology
Case-Control Studies (Retrospective Studies). What is a cohort?
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
Introduction to Risk Factors & Measures of Effect Meg McCarron, CDC.
Measures of Disease Association Measuring occurrence of new outcome events can be an aim by itself, but usually we want to look at the relationship between.
Main Points to be Covered
Cohort Studies.
Applied Epidemiology: Poplhlth 304
Introduction to Study Design and RCTs Simon Thornley.
Manish Chaudhary BPH, MPH
COHORT STUDY DR. A.A.TRIVEDI (M.D., D.I.H.) ASSISTANT PROFESSOR
Incidence and Prevalence
BC Jung A Brief Introduction to Epidemiology - X (Epidemiologic Research Designs: Cohort Studies) Betty C. Jung, RN, MPH, CHES.
Case Control Study Manish Chaudhary BPH, MPH
Cohort Study.
Lecture 3: Measuring the Occurrence of Disease
Multiple Choice Questions for discussion
Week 2. What is epidemiology?  Key science of public health  Focuses on examining the distribution of disease across the population  Use of largely.
Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.
Statistics for clinical research An introductory course.
Research Study Design and Analysis for Cardiologists Nathan D. Wong, PhD, FACC.
Measurement Measuring disease and death frequency FETP India.
Measuring disease and death frequency
Evidence-Based Medicine 3 More Knowledge and Skills for Critical Reading Karen E. Schetzina, MD, MPH.
CHP400: Community Health Program- lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Case Control Studies Present: Disease Past:
ECON ECON Health Economic Policy Lab Kem P. Krueger, Pharm.D., Ph.D. Anne Alexander, M.S., Ph.D. University of Wyoming.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
 Is there a comparison? ◦ Are the groups really comparable?  Are the differences being reported real? ◦ Are they worth reporting? ◦ How much confidence.
Introduction to Epidemiologic Methods Tuesday 9:30 – 10:30 am.
Measures of Association
Study Designs in Epidemiologic
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 8 – Comparing Proportions Marshall University Genomics.
The Impact of Epidemiology in Public Health Robert Hirokawa Epidemiologist, Science and Research Group HHI / TSP, Hawaii Department of Health.
Measuring the Occurrence of Disease 1 Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State.
Case-control study Chihaya Koriyama August 17 (Lecture 1)
Siroli Lily: State Flower of Manipur. Cross- sectional Study Subodh S Gupta MGIMS, Sewagram.
Chapter 2 Nature of the evidence. Chapter overview Introduction What is epidemiology? Measuring physical activity and fitness in population studies Laboratory-based.
Study Designs for Clinical and Epidemiological Research Carla J. Alvarado, MS, CIC University of Wisconsin-Madison (608)
Case Control Study Dr. Ashry Gad Mohamed MB, ChB, MPH, Dr.P.H. Prof. Of Epidemiology.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
Instructor Resource Chapter 11 Copyright © Scott B. Patten, Permission granted for classroom use with Epidemiology for Canadian Students: Principles,
System error Biases in epidemiological studies FETP India.
Overview of Study Designs. Study Designs Experimental Randomized Controlled Trial Group Randomized Trial Observational Descriptive Analytical Cross-sectional.
The Impact of Epidemiology in Public Health Robert Hirokawa, DrPH Epidemiologist, Science and Research Group HHI / TSP, Hawaii Department of Health.
Instructor Resource Chapter 3 Copyright © Scott B. Patten, Permission granted for classroom use with Epidemiology for Canadian Students: Principles,
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
Case-Control Studies Abdualziz BinSaeed. Case-Control Studies Type of analytic study Unit of observation and analysis: Individual (not group)
Descriptive study design
The Basics of Epidemiology. Epidemiology Definition Epidemiology is the study of the distribution and determinants of disease or conditions in human populations.
Introduction to Study Design and RCTs Simon Thornley.
Types of Studies. Aim of epidemiological studies To determine distribution of disease To examine determinants of a disease To judge whether a given exposure.
Case control & cohort studies
Chapter 9: Case Control Studies Objectives: -List advantages and disadvantages of case-control studies -Identify how selection and information bias can.
Instructional Objectives:
Present: Disease Past: Exposure
Comparison of three Observational Analytical strategies
Lecture notes on epidemiological studies for undergraduates
Random error, Confidence intervals and P-values
Epidemiology MPH 531 Analytic Epidemiology Case control studies
Measures of Disease Occurrence
Research Techniques Made Simple: Interpreting Measures of Association in Clinical Research Michelle Roberts PhD,1,2 Sepideh Ashrafzadeh,1,2 Maryam Asgari.
Dr Luis E Cuevas – LSTM Julia Critchley
Summary of Measures and Design
Presentation transcript:

Measures of disease frequency Simon Thornley

Measures of Effect and Disease Frequency Aims – To define and describe the uses of common epidemiological measures of disease frequency and effect

Epidemiology in a nutshell Aim does exposure cause disease? does drug treat disease? Design study Can I randomise? Ethical? Clinical equipoise? Yes No? Observational study Rare disease? One outcome? Case-control (report OR) Rare Exposure? Many outcomes? Cohort (report RR) Randomised study Report (RR) Define case and exposure status Statistical power calculation (type-1, type-2 error, prevalence of disease in unexposed, minimum detectable effect) Is change in exposure distribution temporally related with change in disease distribution?

Table 1 Are there systematic differences between exposure and unexposed groups (confounding) What population is the study sample drawn from? Yes (shouldn’t be in RCT!) Are they adjusted for in the analysis if confounders? Is it representative of underlying population or is there likely selection bias? Population divided by exposure status? Check missing data, duplicates, data range, bivariate scatterplots and lowess curves

Results: Analysis Continuous Categorical Chi-square or Fisher exact test if cell counts <5 t-test Confounders? Review scientific literature… is there likely to be a “Shared common cause of exposure and disease”? Multiple linear regression Logistic regression and or stratification Outcome variable? Check data distributions Transform? Report adjusted measures of association (OR/RR) Report ‘crude’ or univariate measures of association (OR/RR/HR) If difference between crude and adjusted >10%, then Statistical evidence of confounding

Interpret study results Is there an association between exposure and outcome? Is P <0.05 or 95% CI for measure of association contain null value (1)? Bias Yes Exposure is associated with disease No Hypothesis likely false Is there another explanation? Consider type-2 error; confounding, bias, other studies Confounding Information (recall) Selection (survivor; loss to follow up, hosp. controls) Could study design be improved? Type-1 error (consider strength of association) Shared common cause of exposure and disease? Regression or stratified analysis Estimate OR/RR and 95% C. I. How does my study compare with others?

Discussion Is the association I have detected causal? Bradford Hill criteria Temporality: (cohort study? Not cross sectional or case-control which do not separate exposure and disease) Strength of association: (odds ratio or relative risk, does it indicate >50% increase) Dose response: is there increasing association with increased exposure? Biological plausibility: (are there any laboratory studies to support your assertions?) Consistency: (do other studies using different methods, with different groups come up with similar findings?) Experimental evidence: (Any randomised studies?) Analogy: (Any similar findings from related fields of science?) Specificity: Is exposure to the cause reliably followed by disease? Also: are there any other competing explanations? Are there any studies which shed light on these? If not then… Yes (on balance) Exposure causes disease Calculate Risk difference, NNT and PPAR.

How is a disease diagnosed? Limitations?

Methods Clinical – History (symptoms) – Physical examination (physical signs) – Laboratory tests – Radiology – Microbiology Epidemiology – Hospital discharge codes, drug use, lab use, attendance at outpatient clinics, diagnosis codes, autopsy.

Proportions vs Rates Proportions – concerned with (disease) states – Useful for assessing health status of population – Planning health care services – Quality of care – Screening for asymptomatic disease Rates – concerned with (disease) events – Useful for assessing causation

Incidence and Prevalence ↑Incidence ↑Excess Death rate Emigration Immigration Prevalence

Populations Closed – No new members – Loses members to death – Approx when prevalence assessed over short time frame Open – Gains new members – Immigration – Birth – Emigration – Long time period

Prevalence The proportion with disease (at given instant) Adult Population Diabetes

Adult Population Incidence Proportion/ Cumulative incidence/Attack rate Adult Population 2010 (no diabetes) Diabetes Year 2014 per year Incidence proportion= 0.5 Incidence rate impossible to calculate (once diseased, stop being “at risk”).

Incidence Rate Death Get disease

Incidence rate Average rate of disease occurrence over time interval Assumes rate doesn’t change over time Reciprocal of waiting time Years until disease Usually only first event counted; even if biologically, second event may be independent.

Prevalence, incidence and duration of disease If disease is rare:

Duration of disease E.g. Systemic lupus erythematosis Prevalence 0.5% Incidence 6 to 35/100,000 people per year – Say 20.5/100,000 Duration of disease = /(20.5/100,000) – 24 years

Prevalence CHD (men) in NZ

Some questions You are about to design a programme to measure how many people with diabetes are taking appropriate drugs. Would the population of interest consist of prevalent or incident cases of diabetes?

Incidence proportion is: a) Useful for assessing the health status of the population b)The proportion of initially disease free people who, over a specified period of time, develop disease. c) Measures survivors only. d) A rate. e) Measured at one point in time.

Prevalence is: a) Useful for assessing the health status of the population b)The best measure to use when identifying risk factors for a disease c) Unaffected by deaths in the population d)Unaffected by migration e) A rate.

Comparisons Prevalence One point in time; easy to measure Proportion or % Affected by many factors apart from those causing disease. Numerator: count of people with disease Denominator: count of total population at risk No time component Incidence Involves time; difficult to measure Measured as either rate or proportion Less affected by other influences. Numerator: count of people who develop disease during follow-up Denominator: – (prop.) People at risk and disease free – (rate) Person-time at risk.

Summary Prevalence (among population, proportion with historic diagnosis of disease). Incidence proportion (disease free, follow, proportion that develop disease in defined period) Incidence rate (disease free, follow, number of cases that develop disease divided by time at risk).